Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$129.12

-1.53 (-1.17%)

10:09
01/22/19
01/22
10:09
01/22/19
10:09

J&J says government shutdown shouldn't delay PDUFA date for esketamine

  • 22

    Jan

  • 27

    Jan

  • 18

    Feb

JNJ Johnson & Johnson
$129.12

-1.53 (-1.17%)

01/14/19
WELS
01/14/19
NO CHANGE
Target $152
WELS
Outperform
Johnson & Johnson price target lowered to $152 from $162 at Wells Fargo
Wells Fargo analyst Larry Biegelsen lowered his price target for Johnson & Johnson to $152 from $162 ahead of quarterly results. The analyst forecasts Q4 sales of $20.1B and EPS of $1.97, versus consensus of $20.2B and $1.95, respectively. For 2019, Biegelsen expects initial guidance to be conservative based on the company's track record, and J&J to continue to target earnings to grow faster than sales. The analyst sees 5%-6% operational EPS growth as "reasonable." He reiterates an Outperform rating on the shares.
01/04/19
BTIG
01/04/19
NO CHANGE
Target $17
BTIG
Buy
Veracyte price target raised to $17 from $15 at BTIG
BTIG analyst Sung Ji Nam raised his price target on Veracyte (VCYT) to $17 and kept the Buy rating on the shares after its announced long term partnership with Johnson & Johnson (JNJ) yesterday. The analyst says the collaboration aims to accelerate the development of the first nasal swab test for early lung cancer detection and involve the two companies sharing existing data and samples from clinical studies. Sung Ji Nam states that the deal should lead to acceleration of next -gen Percepta launch, adding that the nasal swab test development could quadruple the company's total addressable market value in the U.S. alone.
01/04/19
CANT
01/04/19
NO CHANGE
Target $100
CANT
Overweight
Cantor Fitzgerald analysis suggests others could bid for Celgene
Cantor Fitzgerald analyst Alethia Young reiterates an Overweight rating on Celgene (CELG) with a $100 price target after the company reached an agreement to be acquired by Bristol-Myers Squibb (BMY). Bristol "likely got a good deal, although Celgene has intellectual property and pipeline uncertainties that are key moving pieces," Young tells investors in a research note. Her estimated net present value for Celgene is $80B, assuming some cost synergies, versus the $74B equity valuation in the Bristol deal, excluding the contingent value rights. Young's analysis indicates that companies like Amgen (AMGN) and Johnson & Johnson (JNJ) "could potentially achieve greater commercial synergies." However, the analyst thinks Celgene shareholders "may be satisfied with the current deal after quite a roller-coaster over the past 18 months."
01/02/19
SBSH
01/02/19
NO CHANGE
SBSH
Citi makes four rating changes in Medical Devices, 'warning up' to J&J
Citi analyst Amit Hazan issued his 2019 preview for Medical Devices, which included four rating changes. The analyst upgraded both Zimmer Biomet (ZBH) and Baxter International (BAX) to Buy from Neutral, downgraded Medtronic (MDT) to Neutral from Buy and downgraded Abbott Laboratories (ABT) to Sell from Neutral. He also kept Buy ratings on Intuitive Surgical (ISRG) and Boston Scientific (BSX), but adds he's "relatively more cautious." Further, Hazan kept a Sell rating on Edwards Lifesciences (EW) and says he's "warming up" to Neutral-rated Johnson & Johnson (JNJ). The analyst expects "fairly stable" fundamentals for the group in 2019, with "modest slowdowns" in organic sales and earnings growth.

TODAY'S FREE FLY STORIES

AMRS

Amyris

$3.88

0.05 (1.31%)

17:31
03/19/19
03/19
17:31
03/19/19
17:31
Hot Stocks
Amyris to delay filing 10-K, may have further financial reporting deficiences »

Amyris was unable to file…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$296.55

-1.105 (-0.37%)

17:22
03/19/19
03/19
17:22
03/19/19
17:22
Hot Stocks
Lockheed Martin awarded $264.66M contract modification for Korea F-35 program »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

QHC

Quorum Health

$1.89

-0.02 (-1.05%)

17:20
03/19/19
03/19
17:20
03/19/19
17:20
Hot Stocks
York Capital reports 8.18% passive stake in Quorum Health »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

UPS

UPS

$110.37

-0.31 (-0.28%)

, FDX

FedEx

$181.50

-0.92 (-0.50%)

17:19
03/19/19
03/19
17:19
03/19/19
17:19
Hot Stocks
UPS falls after peer FedEx reports downbeat Q3 results, cuts FY19 EPS view »

UPS (UPS) is dropping in…

UPS

UPS

$110.37

-0.31 (-0.28%)

FDX

FedEx

$181.50

-0.92 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

  • 25

    Apr

BA

Boeing

$373.87

1.77 (0.48%)

17:19
03/19/19
03/19
17:19
03/19/19
17:19
Hot Stocks
Boeing awarded $326.3M Navy delivery order »

Boeing has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

BAYRY

Bayer

$0.00

(0.00%)

17:17
03/19/19
03/19
17:17
03/19/19
17:17
Periodicals
Bayer to face liability in second phase of Roundup trial, Bloomberg says »

Bayer has lost the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

GD

General Dynamics

$170.72

-1.01 (-0.59%)

17:17
03/19/19
03/19
17:17
03/19/19
17:17
Hot Stocks
General Dynamics' Electric Boat awarded $2B contract modification »

The U.S. Navy has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

DIS

Disney

$109.97

-3.1 (-2.74%)

, TFCFA

21st Century Fox

$49.62

(0.00%)

17:14
03/19/19
03/19
17:14
03/19/19
17:14
Hot Stocks
Disney, 21st Century Fox say per share value of merger $51.572626 »

The Walt Disney Company…

DIS

Disney

$109.97

-3.1 (-2.74%)

TFCFA

21st Century Fox

$49.62

(0.00%)

TFCF

21st Century Fox

$49.61

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

MOR

MorphoSys

$23.55

-0.165 (-0.70%)

17:13
03/19/19
03/19
17:13
03/19/19
17:13
Hot Stocks
MorphoSys, I-Mab Biopharma initiate phase 2 study of TJ202 for multiple myeloma »

China-based I-Mab…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 08

    May

ARE

Alexandria Real Estate

$139.70

-0.43 (-0.31%)

17:09
03/19/19
03/19
17:09
03/19/19
17:09
Hot Stocks
Alexandria Real Estate co-CEO sells 3,721 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

XXII

22nd Century

$1.94

0.02 (1.04%)

17:02
03/19/19
03/19
17:02
03/19/19
17:02
Hot Stocks
BlackRock reports 6.5% passive stake in 22nd Century »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTS

Zoetis

$98.72

0.95 (0.97%)

17:00
03/19/19
03/19
17:00
03/19/19
17:00
Initiation
Zoetis initiated at SunTrust »

Zoetis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDM

Piedmont Office Realty

$20.21

-0.27 (-1.32%)

16:59
03/19/19
03/19
16:59
03/19/19
16:59
Hot Stocks
Piedmont Office Realty CEO Miller to retire, Brent smith to succeed »

Piedmont Office Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 22

    Mar

  • 15

    May

TEVA

Teva

$16.91

0.27 (1.62%)

16:56
03/19/19
03/19
16:56
03/19/19
16:56
Initiation
Teva initiated at SunTrust »

Teva initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

FLIC

First Long Island

$22.35

-0.52 (-2.27%)

16:56
03/19/19
03/19
16:56
03/19/19
16:56
Hot Stocks
First Long Island selects Christopher Becker to succeed Michael Vittorio as CEO »

The First of Long Island…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:51
03/19/19
03/19
16:51
03/19/19
16:51
Hot Stocks
Steelcase boosts quarterly dividend 7% to 14.5c per share »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

PRGO

Perrigo

$49.20

0.52 (1.07%)

16:50
03/19/19
03/19
16:50
03/19/19
16:50
Initiation
Perrigo initiated at SunTrust »

Perrigo initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMK

Trustmark

$34.42

-0.7 (-1.99%)

16:50
03/19/19
03/19
16:50
03/19/19
16:50
Downgrade
Trustmark rating change at Keefe Bruyette »

Trustmark downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

WIX

Wix.com

$108.92

1.02 (0.95%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Initiation
Wix.com initiated at Guggenheim »

Wix.com initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CG

Carlyle Group

$19.00

-0.23 (-1.20%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Hot Stocks
Carlyle Group appoints Christopher Finn COO »

Carlyle Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$23.31

-0.23 (-0.98%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Syndicate
Invitation Homes files to sell 43M shares of common stock for holders »

Morgan Stanley & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Earnings
Steelcase sees FY20 EPS $1.20-$1.35, consensus $1.32 »

Sees FY20 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

BA

Boeing

$373.87

1.77 (0.48%)

16:48
03/19/19
03/19
16:48
03/19/19
16:48
Periodicals
Boeing CEO says understands 'lives depend' on jet safety, Reuters says »

Boeing CEO Dennis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:47
03/19/19
03/19
16:47
03/19/19
16:47
Earnings
Steelcase sees Q1 EPS 16c-20c, consensus 20c »

Sees Q1 revenue $830 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

EOLS

Evolus

, AGN

Allergan

$154.13

3.41 (2.26%)

16:46
03/19/19
03/19
16:46
03/19/19
16:46
Initiation
Evolus, Allergan initiated at SunTrust »

Evolus assumed with a Buy…

EOLS

Evolus

AGN

Allergan

$154.13

3.41 (2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 18

    May

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.